Other long-acting GLP-1 analogues Other long-acting GLP-1 analogues are currently being investigated for weight loss in addition to diabetes treatment
Methods: We have identified 138 atrial fibrillation (AF) patients with ischemic stroke from January 2018 to January 2021 who were not suitable to take DOAC and discussed at the institutional brain-heart case conference prior to LAAO
3 months before: Add Glutathione and skin brightening therapies
Administration of EGb (40 mg/kg) and venlafaxine (15 mg/kg) reinstated BDNF expression, enhanced exploratory behavior, and lowered nNOS levels as well as stress-related physiological responses
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias